Table 5 Perceived Effects Scale Scores by Characteristics of 782 Respondents
Relief of Treatment Symptoms | test of association (p value) | Improve Functional Well-being | test of association (p value) | ||
|---|---|---|---|---|---|
(mean scores) | |||||
All Respondents | 0.25 | 0.30 | |||
Percent reporting no net effect | 26% | 37% | |||
Sex | |||||
Male | 0.23 | t | 0.25 | t | |
Female | 0.27 | (0.092) | 0.36 | (< 0.001) | |
Age group | |||||
20 – 49 | 0.30 | 0.42 | |||
50 – 59 | 0.27 | r = -0.03 | 0.29 | r = -0.08 | |
60 – 69 | 0.23 | (0.389) | 0.30 | (0.016) | |
70 and older | 0.25 | 0.26 | |||
Cancer group | |||||
Lung, stomach, liver | 0.23 | F | 0.28 | F | |
Colon, breast, uterus, cervix | 0.29 | (0.060) | 0.35 | (0.004) | |
Prostate, other | 0.21 | 0.15 | |||
Lung | No | 0.27 | t | 0.32 | t |
Yes | 0.20 | (0.032) | 0.26 | (0.190) | |
Stomach | No | 0.25 | t | 0.29 | t |
Yes | 0.27 | (0.379) | 0.34 | (0.245) | |
Liver | No | 0.26 | t | 0.31 | t |
Yes | 0.18 | (0.026) | 0.23 | (0.059) | |
Colon | No | 0.24 | t | 0.29 | t |
Yes | 0.29 | (0.074) | 0.33 | (0.295) | |
Breast | No | 0.25 | t | 0.29 | t |
Yes | 0.26 | (0.725) | 0.36 | (0.192) | |
Uterus | No | 0.25 | t | 0.29 | t |
Yes | 0.39 | (0.075) | 0.50 | (0.051) | |
Cervix | No | 0.25 | t | 0.30 | t |
Yes | 0.26 | (0.836) | 0.42 | (0.159) | |
Prostate | No | 0.25 | t | 0.32 | t |
Yes | 0.21 | (0.277) | 0.14 | (0.002) | |
History using sen-sei-ro | |||||
≤ 3 months | 0.14* | 0.22 | |||
3 – 6 months | 0.24 | r(s) = 0.07 | 0.30 | r(s) = 0.04 | |
6 – 12 months | 0.25 | (0.059) | 0.29 | (0.251) | |
> 12 months | 0.27 | 0.32 | |||
Current treatment | |||||
No active treatment | 0.24 | F | 0.31 | F | |
Oral or radiation therapy | 0.26 | 0.640 | 0.30 | 0.973 | |
Intravenous chemotherapy | 0.26 | 0.30 | |||